ELVN
Enliven Therapeutics (ELVN)
$42
About Enliven Therapeutics (ELVN)
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.
Details
Daily high
$30.22
Daily low
$27.12
Price at open
$27.45
52 Week High
$30.22
52 Week Low
$13.30
Market cap
1.7B
Dividend yield
0.00%
Volume
1.3M
Avg. volume
1.0M
P/E ratio
-15.94
Enliven Therapeutics News
Details
Daily high
$30.22
Daily low
$27.12
Price at open
$27.45
52 Week High
$30.22
52 Week Low
$13.30
Market cap
1.7B
Dividend yield
0.00%
Volume
1.3M
Avg. volume
1.0M
P/E ratio
-15.94